GlassScriptPhysician profile
Robert A Salazar
NPI 1508800251
$23,955.47
in general payments reported to CMS, 2019-2025
58 companies · $4,078 in 2025
The $4,078 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,736 · 2020: $1,588 · 2021: $3,738 · 2022: $3,420 · 2023: $3,661 · 2024: $3,734 · 2025: $4,078.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,927 · Consulting Fee: $1,250 · Travel and Lodging: $1,240 · Education: $56.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,926.89 |
| Consulting Fee | $1,250.00 |
| Travel and Lodging | $1,240.09 |
| Education | $56.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,219.64 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $2,597.92 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Electromed, INC. | $2,266.34 | 2021-2025 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,283.88 | 2019-2025 | Ofev, Jascayd |
| Inari Medical, INC. | $1,246.12 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $1,210.22 | 2021-2025 | Indigo System |
| Mylan Specialty L.P. | $964.98 | 2019-2024 | Yupelri |
| Hill-Rom Services, INC | $875.00 | 2021 | |
| Abiomed | $768.74 | 2019-2024 | Impella |
| Itamar Medical INC | $750.00 | 2023 | Watchpatone |
| Philips North America LLC | $684.54 | 2019-2024 | (2383) Sleepundivided, (Ak6) Vest Therapy |
| Jazz Pharmaceuticals INC. | $676.09 | 2019-2023 | |
| Genzyme Corporation | $654.25 | 2019-2025 | |
| Insmed, INC. | $597.50 | 2022-2025 | Arikayce |
| Grifols USA, LLC | $591.36 | 2019-2025 | Prolastin-C Liquid |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $535.58 | 2021-2025 | Dupixent |
| Genentech USA, INC. | $467.39 | 2019 | |
| Amgen INC. | $396.03 | 2023-2025 | Tezspire, Tavneos |
| Harmony Biosciences LLC | $367.95 | 2020-2025 | Wakix |
| Medtronic, INC. | $339.24 | 2024-2025 | Symplicity G3, Cobalt Dr Mri Surescan, Turbohawk |
| Viatris Specialty LLC | $267.03 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $252.05 | 2021-2025 | Inspire |
| Janssen Pharmaceuticals, INC | $219.12 | 2020-2023 | Xarelto |
| Verona Pharma, INC. | $201.71 | 2025 | Ohtuvayre |
| Allergan, INC. | $191.21 | 2019 | |
| Tactile Systems Technology INC | $171.22 | 2021-2024 | Flexitouch Plus, Entre Plus |
| Pulmonx Corporation | $169.57 | 2022-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Boston Scientific Corporation | $168.18 | 2021-2022 | |
| United Therapeutics Corporation | $161.86 | 2021-2023 | Tyvaso |
| Idorsia Pharmaceuticals US INC | $146.89 | 2022-2024 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $144.12 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $135.84 | 2020-2022 | |
| Vifor Pharma, INC. | $121.92 | 2019 | |
| Optinose US, INC. | $111.77 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $103.09 | 2019-2020 | |
| Inogen, INC. | $101.75 | 2020-2025 | |
| Axsome Therapeutics, INC. | $95.99 | 2023-2025 | Sunosi |
| Shionogi INC | $93.39 | 2021-2023 | Fetroja |
| Circassia INC. | $64.48 | 2019-2021 | |
| Medtronic Vascular, INC. | $64.31 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $62.81 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $55.02 | 2020-2021 | |
| Eisai INC. | $45.47 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $35.63 | 2021-2025 | Nuzyra |
| Resmed Corp | $32.07 | 2019-2022 | |
| Lilly USA, LLC | $29.14 | 2025 | Zepbound |
| 3b Medical, INC. | $28.24 | 2023 | Luna |
| Pfizer INC. | $27.55 | 2023 | |
| Gilead Sciences, INC. | $27.51 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.09 | 2020 | |
| Nabriva Therapeutics, Plc | $20.67 | 2021 | |
| Advanced Respiratory, INC | $18.36 | 2019 | |
| Shire North American Group INC | $18.27 | 2019 | |
| Melinta Therapeutics, LLC | $16.60 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $15.88 | 2022 | |
| Ambu INC. | $15.28 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7.61 | 2023 | Lifevest |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Salazar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.